<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tokyo_Tech_Safety"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tokyo_Tech/Safety">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tokyo_Tech/Safety&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Safety&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Safety&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tokyo_Tech/Safety" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tokyo Tech/Safety</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><P><TITLE>Tokyo_Tech</TITLE></P><DIV id="wrapper"><DIV id="menu"><UL><LI><A href="https://2014.igem.org/Team:Tokyo_Tech">Home</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Project">Project</A></LI><LI><A href="#">Experiment</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Plux and Prhl reporter assay" style="width:400px; margin-left:-135px;">Plux and Prhl reporter assay</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Prhl_reporter_assay" style="width:400px; margin-left:-135px;">Improved Prhl reporter assay</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Mutualism Confirmation ~Co-culture Assay~</A></LI></UL><LI><A href="#">Modeling</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Overview" style="width:400px; margin-left:-135px;">Overview</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Growth Conditions For Company And Customer" style="width:400px; margin-left:-135px;">Growth Conditions For Company And Customer</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Analysis of C4HSL-dependent Switch" style="width:400px; margin-left:-135px;">Analysis of C4HSL-dependent Switch</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Economic Wave" style="width:400px; margin-left:-135px;">Economic Wave</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Parts">Parts</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Policy_and_Practices" style="height:50px; padding-top:3px;">Policy and Practices</A></LI><LI class="current_page_item"><A href="#">More</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/About_Us" style="width:240px; margin-left:-53px;">About Us</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Safety" style="width:240px; margin-left:-53px;">Safety</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Attribution_and_Contribution" style="width:240px; margin-left:-53px;">Attribution and Contribution</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Collaboration" style="width:240px; margin-left:-53px;">Collaboration</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Judging_Form" style="width:240px; margin-left:-53px;">Judging Form</A></LI><LI><A href="https://2014.igem.org/Team:Tokyo_Tech/Sponsors" style="width:240px; margin-left:-53px;">Sponsors</A></LI><LI><A href="https://igem.org/Team.cgi?id=1529" style="width:240px; margin-left:-53px;">Official Team Page</A></LI></DIV><DIV id="page"><DIV id="content_normal"><DIV class="post"><H2 class="title">Safety</H2><SPAN class="meta">Safety information for our organisms </SPAN><DIV class="entry-long"><TABLE width="900" border="0"><TBODY><TR><TD> </TD></TR><TR><TD class="title-small"><DIV align="center">Safety Form </DIV></TD></TR><TR><TD> </TD></TR><TR><TD> </TD></TR><TR><TD class="head">1.) Your Training </TD></TR><TR><TD class="entry"> </TD></TR><TR><TD class="info-18"><STRONG>a) Have your team members received any safety training yet?</STRONG></TD></TR><TR><TD class="info">- Yes,we have already received safety training.</TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>b) Please briefly describe the topics that you learned about (or will learn about) in your safety training.</STRONG></TD></TR><TR><TD class="info">- Microbiological experiments (including recombinant DNA) Safety in Recombinant DNA Experiments </TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>c) Please give a link to the laboratory safety   training requirements of your institution (college, university,   community lab, etc). Or, if you cannot give a link, briefly describe the   requirements.</STRONG></TD></TR><TR><TD class="info">- SAFETY HANDBOOK wrote by Committee for Practice on management of Safety in Tokyo Institure Microbiological experiments (including recombinant DNA) </TD></TR><TR><TD> </TD></TR><TR><TD> </TD></TR><TR><TD class="head">2.) Your Local Rules and Regulations</TD></TR><TR><TD class="entry"> </TD></TR><TR><TD class="info-18"><STRONG>a) Who is responsible for biological safety at   your institution? (You might have an Institutional Biosafety Committee,   an Office of Environmental Health and Safety, a single Biosafety   Officer, or some other arrangement.) Have you discussed your project   with them? Describe any concerns they raised, and any changes you made   in your project based on your discussion.</STRONG></TD></TR><TR><TD class="info">- Our institute has recombinant DNA committee </TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>b) What are the biosafety guidelines of your   institution? Please give a link to these guidelines, or briefly describe   them if you cannot give a link.</STRONG></TD></TR><TR><TD class="info">- <A href="http://www.rpd.titech.ac.jp//rpdiv/somu/docs/idenshikumikaejikken_anzenkanrikisoku.pdf">http://www.rpd.titech.ac.jp//rpdiv/somu/docs/idenshikumikaejikken_anzenkanrikisoku.pdf</A></TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>c) In your country, what are the regulations   that govern biosafety in research laboratories? Please give a link to   these regulations, or briefly describe them if you cannot give a link.</STRONG></TD></TR><TR><TD class="info"><A href="http://www.lifescience.mext.go.jp/bioethics/anzen.html">- http://www.lifescience.mext.go.jp/bioethics/anzen.html</A></TD></TR><TR><TD> </TD></TR><TR><TD> </TD></TR><TR><TD><SPAN class="head">3.) The Organism and Parts that You Use </SPAN></TD></TR><TR><TD class="entry"> </TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: ppX</H3><H3 class="info-18">*Natural function of part:  exopolyphosphatase</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?:  exopolyphosphatase</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: phoU </H3><H3 class="info-18">*Natural function of part:  regulation of the phosphate regulon</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?:  regulation of the phosphate regulon</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: ydeD </H3><H3 class="info-18">*Natural function of part:  transportation of cystein</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?:  transportation of cystein</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: yfiK</H3><H3 class="info-18">*Natural function of part:  transportation of cystein</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?:  transportation of cystein</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source:<A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: rpoS </H3><H3 class="info-18">*Natural function of part:  regulation of transcription</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?: regulation of transcription, growth inhibition</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 1</H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: crl</H3><H3 class="info-18">*Natural function of part:  regulation of transcription, activagtor of rpoS</H3><H3 class="info-18">*How did you acquire it: made by PCR</H3><H3 class="info-18">*How will you use it?: regulation of transcription, activagtor of rpoS</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: Burkholderia glumae </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 2 </H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: obcA </H3><H3 class="info-18">*Natural function of part:  synthesis of oxalic acid</H3><H3 class="info-18">*How did you acquire it: Gene synthesis by IDT</H3><H3 class="info-18">*How will you use it?:  synthesis of oxalic acid</H3></TD></TR><TR><TD> </TD></TR><TR><TD><H1>*Species: <I>E. coli</I> MG1655 </H1></TD></TR><TR><TD> </TD></TR><TR><TD><H3 class="info-18">*Risk Group: 2 </H3><H3 class="info-18">*Risk Group Source: <A href="http://osp.od.nih.gov/office-biotechnology-activities/biosafety/nih-guidelines">NIH Guidelines </A></H3><H3 class="info-18"> *Disease risk to humans:No</H3><H3 class="info-18">*Part number/name: obcB</H3><H3 class="info-18">*Natural function of part:  synthesis of oxalic acid</H3><H3 class="info-18">*How did you acquire it: Gene synthesis by IDT</H3><H3 class="info-18">*How will you use it?:  synthesis of oxalic acid</H3></TD></TR><TR><TD> </TD></TR><TR><TD> </TD></TR><TR><TD class="head">4.) Risks of Your Project Now </TD></TR><TR><TD class="entry"> </TD></TR><TR><TD class="info-18"><STRONG>a) Risks to the safety and health of team members, or other people working in the lab:</STRONG></TD></TR><TR><TD class="info">- Without drinking large amount of sample, there is no risk.Such taking might cause irritation to skin,eyes,and respiratory tract.</TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>b) Risks to the safety and health of the general public (if any biological materials escaped from your lab):</STRONG></TD></TR><TR><TD class="info">- Wihtout drinking large amount of sample, there is no risk.Such taking might cause irritation to skin,eyes,and respiratory tract.</TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>c) Risks to the environment (from waste disposal, or from materials escaping from your lab):</STRONG></TD></TR><TR><TD class="info">- Production of AHL might perturbate communications in wild bacteria.</TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>d) Risks to security through malicious mis-use by individuals, groups, or countries:</STRONG></TD></TR><TR><TD class="info">- Use of plant hormone in the opposite direction could disrupt growth of crops.Malicious usage of phage might pertubate intestinal flora.</TD></TR><TR><TD> </TD></TR><TR><TD class="info-18"><STRONG>e) What measures are you taking to reduce these risks? (For example: safe lab practices, choices of which organisms to use.)</STRONG></TD></TR><TR><TD class="info">- Do not eat,drink,smoke,prepare or store foods in laboratories.
                     -
                Wear a lab-coat(white coat) while you are in a bio-lab.
                     -                Keep the lab tidy and clean.
                     -                Put labels on containers.
                   -              Practice disinfection,sterilization,and washing hands.</TD></TR><TR><TD class="info"> </TD></TR><TR><TD class="head">5.) Risks of Your Project in the Future </TD></TR><TR><TD class="entry"> </TD></TR><TR><TD class="info-18"><STRONG>a) What <EM>new</EM> risks might arise from your   project's growth? (Consider the categories of risk listed in parts a-d   of the previous question: lab workers, the general public, the   environment, and malicious mis-uses.) Also, what risks might arise if   the <EM>knowledge</EM> you generate or the <EM>methods</EM> you develop became widely available?</STRONG></TD></TR><TR><TD class="info">- Excess produce of oxalic acid may cause urinary stone.(a)
                     -
                We can farm any poisonous plants easily. (b)
                     -
                Too many phosphate may cause contamination of environment.(c)
                   -
              Diabetes patient may have danger if he or she intakes Cystein over 1500mg.(a)</TD></TR><TR><TD class="info"> </TD></TR><TR><TD class="info-18"><STRONG>b) Does your project currently include any   design features to reduce risks? Or, if you did all the future work to   make your project grow into a popular product, would you plan to design   any new features to minimize risks? (For example: auxotrophic chassis,   physical containment, etc.) Such features are not required for an iGEM   project, but many teams choose to explore them.</STRONG></TD></TR><TR><TD class="info">- We have to consider potential risks in Bioremediation.
              When our project grow, limitation of solid use will be needed.</TD></TR></TBODY></TABLE></DIV></DIV></DIV><DIV style="clear: both;"> </DIV></DIV><DIV id="footer-over"><P>© Tokyo Institute of Technology iGEM 2014</P></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Tokyo_Tech/Safety">http://2014.igem.org/Team:Tokyo_Tech/Safety</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tokyo_Tech/Safety" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tokyo_Tech/Safety" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Safety&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Safety&amp;oldid=381623" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></BODY></HTML>